Training My Thoughts
October 22, 2021
Why TFF's Hamster Data Is Bigger Than Investors Think
October 15, 2021
TFF Pharmaceuticals and Augmenta Bioworks Publish Positive In Vivo Data Showing Dry Powder Formulation of COVID-19 Antibody, AUG-3387, Neutralizes SARS-CoV-2 Infection and Reduces Viral Load
October 14, 2021
October 2, 2021
When The Tide Goes Out, You See Who's Swimming Naked...
September 18, 2021
A September To Remember?
September 4, 2021
Alzheimer’s Patients Treated with INmune Bio’s XPro™ Show Reduction in CSF Phospho-Tau and Evidence of Remyelination
September 1, 2021
INKmune Induces Memory-Like NK Cells...This Is A Very Big Deal
August 26, 2021
Old Fashioned Sunday
August 21, 2021
INKmune: An Interview With INmune Bio's Dr. Mark Lowdell
August 18, 2021
All our articles are free for everyone to enjoy, however you must register as a user. Please take the time to sign up, it’s free and we do not share your information with anyone.
For those interested in receiving alerts when we buy or sell stocks for our managed accounts, you should consider becoming a premium subscriber. A premium subscription costs $500 per year and subscribers get emails about every transaction taken in our portfolios, including names that have yet to be added to the Tailwinds site.
DFC Advisory Services LLC (dba TW Research Group) is an investment adviser. We are also compensated for publishing information on certain companies. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.